Revon Media
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us
No Result
View All Result
Revon Media
No Result
View All Result

IJN and Novartis tackle heart disease

IJN and Novartis tackle heart disease
Share on FacebookShare on Twitter

The National Heart Institute (IJN) and multinational pharmaceutical firm Novartis Malaysia have partnered to help Malaysians take better care of their heart. The collaboration aimed to help patients improve disease management of Atherosclerotic Cardiovascular Disease (ASCVD) through better care and therapies.

ASCVD diseases like coronary heart disease (CHD), stroke, and peripheral arterial disease (PAD) are caused by the buildup of high cholesterol levels and the hardening and narrowing of arteries.

Novartis Malaysia Country President Mohamed El-Wakil said that the World Health Organisation (WHO) estimates that over 15 million people die annually from ASCVD. This accounts for 85 per cent of global cardiovascular death.

Meanwhile, Malaysia’s National Health and Morbidity Survey 2019 reported that non-communicable diseases (NCDs) like ASCVD accounted for 71 per cent of premature deaths in the country.

“Of key concern within NCDs is ASCVD which contributes to 54 per cent of all NCD deaths. This pioneering collaboration between Novartis Malaysia and IJN is crucial as it can be a potential game-changer within the ASCVD treatment paradigm. It brings together the expertise and impeccable standards of care by the nation’s premier cardiovascular specialist institution, IJN, together with the comprehensive experience of Novartis in the area of cardiovascular,” said Mohamed Elwakil, Novartis Malaysia Country President.

IJN CEO Datuk Dr Aizai Azan Abdul Rahim said, the collaboration couldn’t have come at a better time with the prevalence of ASVCD in Malaysia. He hopes the project will achieve its goal of showcasing the best of ASCVD care.

“In addition, the Health Ministry has just revealed the National Strategic Plan for Non-Communicable Disease (NCD) 2016 – 2025, aiming to reduce NCD deaths from 20 per cent to 15 per cent by 2025. We look forward to our collaboration with Novartis
Malaysia to achieve our goal of ‘What Goods Looks Like’ in ASCVD care,” said Dr Aizai.

The project will be focused on:

• Research collaboration to generate data on ASCVD in Malaysia and measure outcomes of ASCVD patients.

• Establishing IJN as an internationally recognized training centre of excellence in ASCVD care.

• The establishment of a state-of-the-art multi-disciplinary Cardiovascular Risk Reduction Clinic (CRRC) to optimise ASCVD care.

• The CRRC was successfully launched at IJN and is hosted every Monday. The clinic provides risk management treatment for patients with cardiovascular disease and primary lipid disorders to optimize ASVCD care. – The Health

Tags: Atherosclerotic Cardiovascular Disease (ASCVD)Heart healthIJNLocal NewsNovartisThe Health 2022The Health OctThe Health Oct 2022The National Heart InstitutetheHealth
Previous Post

Kerry’s new RM15.89m site in Malaysia

Next Post

Intervenn Biosciences makes Malaysia regional hub

Live Edition Paper

NOV 2020 ePaper

OCT 2020 ePaper


 

Subscribe for free complimentary live editions:

Recent News

  • Astigmatism is not life threatening?
    October 6, 2021
    It is vital to see an optometrist to get checked and diagnosed for astigmatism […]
  • Is an H-index of 13 shameful?
    September 30, 2021
    It is misleading to compare the research in African Arabian countries as they […]
  • Vaccine boost
    March 1, 2021
    National Covid-19 Immunisation Programme kicks off with 637,000 individuals […]
  • Futuristic hospitals
    September 30, 2021
    The Ministry of Health will work hand-in-hand with relevant authorities to […]
  • Supporting those with advanced and metastatic cancer
    December 22, 2022
    The Breast Cancer Welfare Association Malaysia (BCWA), Lung Cancer Network […]

Connect

Office

Revon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.

Contact

Tel: +603 3359 1166
Fax: +6 03 3358 0303

Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use

No Result
View All Result
  • Newspaper
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Live Edition
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • Media
    • theHealth
    • @Halal
    • @green
    • @Pancing
    • myHealth
  • About Us
  • Contact Us

© 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist